Home  /  Resource Library  /  Reduced CD20 Expression yields Inferior Survival in Patients with B Cell Lymphoma Treated with CD20xCD3 Antibodies

Reduced CD20 Expression yields Inferior Survival in Patients with B Cell Lymphoma Treated with CD20xCD3 Antibodies